Cryosurgery can be used for the treatment of benign and malignant tumors in various medical disciplines. In dermatology, cryosurgery can be employed, for example, for solar keratosis, cornu cutaneum, leukoplakia, extramammary Paget's disease, keratoacanthoma, spinocellular carcinoma, and basal-cell cancer. The possible application of cryosurgery for the treatment of malignant melanoma is based on the following facts and assumptions: 1. 1. The cold-induced destruction of melanoma cells occurs at temperatures of −4 ° C to −7 ° C, while connective tissue cell destruction is only observed at temperatures below −20 ° C. 2. 2. As discussed in Chapter 3 “Electron Microscopic Investigations of the Cryolesion,” electron microscopic studies of cryolesions have shown that cell membranes, intracellular organelles, and the nucleus are destroyed. 3. 3. There are indications that humoral as well as cell-mediated immune responses are induced by cryotherapy. The destroyed tumor remains in situ, giving rise to the possibility of prolonged exposure (about 72 hours) of tumor antigens to the host's immune system. As a consequence, it can be postulated that tissue destroyed by freezing is capable of immune system stimulation in two ways. The first is via the release of intracellularly sequestered auto-antigens into the bloodstream as a result of cell membrane destruction. Once in the bloodstream, contact is made with the immune system which does not recognize these antigens as “self.” The second alternative is an alteration of the membrane molecular surface structure to such an extent that the immune system mistakes them as foreign antigens and mounts an immune response. The higher the cooling intensity or the larger the cryolesion, the more antigenic material will be released, apparently leading to a greater “immunologic stimulation” of the host. 1,3 The use of cryostimulation as an adjuvant, active and specific immunotherapy in addition to the cryosurgical destruction of malignant melanoma is, therefore, of considerable interest. There are two different possibilities for application of cryosurgery in CMM: cryosurgery of primary malignant melanoma, and palliative cryosurgery of metastases from stages II–IV.
Read full abstract